Neoadjuvant Therapy for Gastric Cancer.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 9, p. 1219
- By:
- Publication type:
- Article
Works matching AU Chadha, Manpreet K.
Results: 6
1
2
Phase 2 Trial of Weekly Intravenous 1,25 Dihydroxy Cholecalciferol (Calcitriol) in Combination With Dexamethasone for Castration-Resistant Prostate Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 9, p. 2132, doi. 10.1002/cncr.24973
- By:
- Publication type:
- Article
3
Titanium dioxide replacement with inorganic alternatives for color‐masking of ferrous fumarate in double fortified salt.
- Published in:
- JSFA Reports, 2025, v. 5, n. 4, p. 128, doi. 10.1002/jsf2.231
- By:
- Publication type:
- Article
4
Vitamin D deficiency and insufficiency among patients with prostate cancer.
- Published in:
- BJU International, 2009, v. 104, n. 7, p. 909, doi. 10.1111/j.1464-410X.2009.08531.x
- By:
- Publication type:
- Article
5
Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients.
- Published in:
- Prostate, 2011, v. 71, n. 4, p. 368, doi. 10.1002/pros.21250
- By:
- Publication type:
- Article
6
Phase II study of fulvestrant (faslodex®) in castration resistant prostate cancer.
- Published in:
- Prostate, 2008, v. 68, n. 13, p. 1461, doi. 10.1002/pros.20813
- By:
- Publication type:
- Article